Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/25 21:30 | 2/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 4 | S.d | -4,273 | 46.02 | 0 | -93 | 716 | D | |||||||||||||||
2/7/25 18:05 | 2/5/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 4 | S.d | -3,070 | 52.37 | 0 | -59 | 198 | D | |||||||||||||||
2/5/25 09:03 | 2/3/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | 4 | S | -1,217 | 37.44 | 0 | -33 | 311 | D | |||||||||||||||
1/31/25 09:14 | 1/27/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 4 | S.d | -6,099 | 53.24 | 0 | -115 | 96 | D | |||||||||||||||
1/29/25 20:43 | 1/27/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Lamy Patrick | CA | O | SVP,Comm | 3 | S.d | -343 | 49.50 | 0 | -7 | 34 | D | |||||||||||||||
12/12/24 20:26 | 12/10/24 | AKRO | Health | Drug | Pharmaceutical Preparations | White William Richard | CA | O | CFO | 1 | S | -87 | 30.79 | 0 | -3 | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |